To investigate the role of TAGLN2 and CRNN in ESCC progression, we selected a PDX case (LEG404) with higher TAGLN2 expression and lower CRNN expression from our established ESCC PDX models (Supplementary Fig. 7b). Here, TAGLN2 is linked to esophageal squamous cell carcinoma.